Bayer Yakuhin Obtains Approval For Glucobay Oral Disintegration Tablets
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Bayer Yakuhin obtained Japanese approval for an oral disintegration formulation of Glucobay (acarbose) for patients with diabetes